Dr. Paul Lynch is a double board-certified and Fellowship-trained interventional pain management specialist who has dedicated his life to the eradication of pain for his patients.
Dr. Lynch is passionate about diagnosing the most complex pain conditions and treating those patients with cutting-edge and innovative therapies, like stem cell injections and spinal cord stimulation. Dr. Lynch is also the co-founder and sits on the Board of Directors for Pain Doctor, Inc. Pain Doctor is a leading pain management company committed to delivering the highest quality, evidence-based and affordable pain care to patients throughout the U.S.
He currently practices in Scottsdale, AZ and also is the co-founder of Arizona Pain, PainDoctor.com, Holistic Pain, and Boost Medical. Dr. Lynch studied at Beth Israel Medical Center in New York City, New York University, Texas Tech University, and was an Assistant Professor at Mayo Clinic College of Medicine. In addition to his education, Dr. Lynch is also a member of several professional societies including ASIPP, ISIS, and AAPM.
Dr. Lynch is also passionate about educating the public about responsible opioid management and reduction. Throughout his career, he’s focused on helping his patients reduce or stop their opioid use, due to the harmful side effects and risks from these medications. For many patients, he’s able to significantly reduce their dosage rates by using a combination of complementary therapies and interventional procedures to manage their pain.
As one of the foremost practitioners in his field, Dr. Paul Lynch is committed to helping his patients lead fuller lives with chronic pain.
Practice Info: Arizona Pain was founded on a single premise–provide world-class care that we would want for our own mom or dad. We use a team approach with cutting edge treatment plans as we ask one simple question with every patient.
Dr. Lynch studied at Beth Israel Medical Center in New York City, New York University, Texas Tech University
Assistant Professor at Mayo Clinic College of Medicine.